Welcome to LookChem.com Sign In|Join Free

CAS

  • or

16724-63-3

Post Buying Request

16724-63-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

16724-63-3 Usage

General Description

Dihexadecylamine is a long-chain primary amine compound with the chemical formula C32H67N. It is commonly used as a surfactant in various industrial processes, as well as a corrosion inhibitor, and as an intermediate in the production of other chemicals. Dihexadecylamine is known for its ability to lower the surface tension of liquids and facilitate the dispersion of solids in liquids, making it a useful ingredient in the formulation of detergents, emulsifiers, and lubricants. It is also used in the synthesis of quaternary ammonium compounds and in the manufacturing of various pharmaceuticals and agrochemicals. Additionally, dihexadecylamine is used in the production of cationic polymers and can be found in some personal care products.

Check Digit Verification of cas no

The CAS Registry Mumber 16724-63-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,7,2 and 4 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 16724-63:
(7*1)+(6*6)+(5*7)+(4*2)+(3*4)+(2*6)+(1*3)=113
113 % 10 = 3
So 16724-63-3 is a valid CAS Registry Number.
InChI:InChI=1/C32H67N/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h33H,3-32H2,1-2H3

16724-63-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name N,N-dihexadecylamine

1.2 Other means of identification

Product number -
Other names N-hexadecylhexadecan-1-amine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:16724-63-3 SDS

16724-63-3Synthetic route

hexadecylamine
143-27-1

hexadecylamine

dihexadecylamine
16724-63-3

dihexadecylamine

Conditions
ConditionsYield
With Co2Rh2/C In toluene at 180℃; under 760.051 Torr; for 18h; Autoclave; Inert atmosphere;97%
In aluminum nickel; water; benzene73%
With nickel at 200℃;
hexadecylamine
143-27-1

hexadecylamine

1-Hexadecanol
36653-82-4

1-Hexadecanol

dihexadecylamine
16724-63-3

dihexadecylamine

Conditions
ConditionsYield
With platinum-titanium/titanium oxide catalyst In toluene at 120℃; for 48h; Temperature; Solvent; Reagent/catalyst; Sealed tube;95%
N,N-Dihexadecyl-2-(tetrahydro-pyran-2-yloxymethyl)-benzamide
211438-74-3

N,N-Dihexadecyl-2-(tetrahydro-pyran-2-yloxymethyl)-benzamide

dihexadecylamine
16724-63-3

dihexadecylamine

Conditions
ConditionsYield
With water; acetic acid In tetrahydrofuran at 60℃; for 4h;76%
hexadecylamine
143-27-1

hexadecylamine

n-hexadecanoyl chloride
112-67-4

n-hexadecanoyl chloride

dihexadecylamine
16724-63-3

dihexadecylamine

Conditions
ConditionsYield
Stage #1: hexadecylamine; n-hexadecanoyl chloride With dmap; triethylamine In toluene at 20℃; for 48h;
Stage #2: With lithium aluminium tetrahydride In tetrahydrofuran for 18h; Heating;
65%
Stage #1: hexadecylamine; n-hexadecanoyl chloride
Stage #2: With lithium aluminium tetrahydride Further stages.;
Multi-step reaction with 2 steps
1: triethylamine / dichloromethane / 20 °C
2: lithium aluminium tetrahydride / tetrahydrofuran / 20 °C
View Scheme
hexadecylamine
143-27-1

hexadecylamine

hexadecanyl bromide
112-82-3

hexadecanyl bromide

dihexadecylamine
16724-63-3

dihexadecylamine

Conditions
ConditionsYield
With sodium carbonate In ethanol for 116h; Reflux;59%
With potassium carbonate In ethanol for 120h; Reflux;50.2%
With sodium carbonate In ethanol for 116h; Heating;27%
With sodium carbonate
hexadecylamine
143-27-1

hexadecylamine

1-iodohexadecane
544-77-4

1-iodohexadecane

A

dihexadecylamine
16724-63-3

dihexadecylamine

B

trihexadecylamine
28947-77-5

trihexadecylamine

Conditions
ConditionsYield
at 180℃;
1-Chlorohexadecan
4860-03-1

1-Chlorohexadecan

A

hexadecylamine
143-27-1

hexadecylamine

B

dihexadecylamine
16724-63-3

dihexadecylamine

Conditions
ConditionsYield
With ethanol; ammonia at 170℃;
palmitanilide
6832-98-0

palmitanilide

dihexadecylamine
16724-63-3

dihexadecylamine

Conditions
ConditionsYield
With 1,4-dioxane; Ba containing copper chromite at 270 - 290℃; under 154457 Torr; Hydrogenation;
hexadecanyl bromide
112-82-3

hexadecanyl bromide

dihexadecylamine
16724-63-3

dihexadecylamine

Conditions
ConditionsYield
With ethanol Kochen des gebildeten Dihexadecyl-cyanamids mit verd. H2SO4;
Palmitamide
629-54-9

Palmitamide

dihexadecylamine
16724-63-3

dihexadecylamine

Conditions
ConditionsYield
With 1,4-dioxane; Ba containing copper chromite at 270 - 290℃; under 154457 Torr; Hydrogenation;
With zinc oxide-chromium oxide at 315 - 330℃; under 147102 - 176522 Torr; Hydrogenation;
Multi-step reaction with 3 steps
1: lithium aluminium tetrahydride / tetrahydrofuran / 1 h
2: triethylamine / dichloromethane / 20 °C
3: lithium aluminium tetrahydride / tetrahydrofuran / 20 °C
View Scheme
With nickel at 225 - 245℃; under 125036 - 147102 Torr; Hydrogenation;
1,4-dioxane
123-91-1

1,4-dioxane

Palmitamide
629-54-9

Palmitamide

copper chromite

copper chromite

dihexadecylamine
16724-63-3

dihexadecylamine

Conditions
ConditionsYield
at 270 - 280℃; under 73550.8 Torr; Hydrogenation;
hexadecylamine
143-27-1

hexadecylamine

Raney nickel

Raney nickel

dihexadecylamine
16724-63-3

dihexadecylamine

Conditions
ConditionsYield
at 200℃;
ethanol
64-17-5

ethanol

1-Chlorohexadecan
4860-03-1

1-Chlorohexadecan

ammonia
7664-41-7

ammonia

A

hexadecylamine
143-27-1

hexadecylamine

B

dihexadecylamine
16724-63-3

dihexadecylamine

Conditions
ConditionsYield
at 170℃;
Hexadecyl-hexadec-(Z)-ylidene-amine

Hexadecyl-hexadec-(Z)-ylidene-amine

dihexadecylamine
16724-63-3

dihexadecylamine

Conditions
ConditionsYield
With sodium tetrahydroborate In methanol; dichloromethane at 20℃; for 4h;
With sodium tetrahydroborate In methanol; dichloromethane at 0 - 20℃; for 4h;
Dihexadecyl-cyanamide
74438-80-5

Dihexadecyl-cyanamide

dihexadecylamine
16724-63-3

dihexadecylamine

Conditions
ConditionsYield
With sulfuric acid for 8h; Heating;35.8 g
hexadecanyl bromide
112-82-3

hexadecanyl bromide

dihexadecylamine
16724-63-3

dihexadecylamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: NaOH; Aliquat 336 / H2O; toluene / 8 h / 50 °C
2: 35.8 g / aq. H2SO4 / 8 h / Heating
View Scheme
n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

dihexadecylamine
16724-63-3

dihexadecylamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: MgSO4 / CH2Cl2 / 0 - 20 °C
2: NaBH4 / CH2Cl2; methanol / 4 h / 20 °C
View Scheme
Multi-step reaction with 2 steps
1: MgSO4 / CH2Cl2 / 3 h / 0 - 20 °C
2: NaBH4 / CH2Cl2; methanol / 4 h / 0 - 20 °C
View Scheme
methanesulfonic acid hexadecyl ester
20779-14-0

methanesulfonic acid hexadecyl ester

dihexadecylamine
16724-63-3

dihexadecylamine

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: t-BuOK / dimethylformamide / 1 h / Ambient temperature
2: NaBH4 / propan-2-ol; toluene; H2O / 4 h / 0 °C
3: p-TsOH / CH2Cl2 / 2 h / Ambient temperature
4: 73 percent / dimethylformamide / 6 h / 40 °C
5: 76 percent / AcOH, H2O / tetrahydrofuran / 4 h / 60 °C
View Scheme
N-hexadecyl-phthalimide
61020-43-7

N-hexadecyl-phthalimide

dihexadecylamine
16724-63-3

dihexadecylamine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: NaBH4 / propan-2-ol; toluene; H2O / 4 h / 0 °C
2: p-TsOH / CH2Cl2 / 2 h / Ambient temperature
3: 73 percent / dimethylformamide / 6 h / 40 °C
4: 76 percent / AcOH, H2O / tetrahydrofuran / 4 h / 60 °C
View Scheme
N-Hexadecyl-2-hydroxymethyl-benzamide
211438-65-2

N-Hexadecyl-2-hydroxymethyl-benzamide

dihexadecylamine
16724-63-3

dihexadecylamine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: p-TsOH / CH2Cl2 / 2 h / Ambient temperature
2: 73 percent / dimethylformamide / 6 h / 40 °C
3: 76 percent / AcOH, H2O / tetrahydrofuran / 4 h / 60 °C
View Scheme
N-Hexadecyl-2-(tetrahydro-pyran-2-yloxymethyl)-benzamide
211438-69-6

N-Hexadecyl-2-(tetrahydro-pyran-2-yloxymethyl)-benzamide

dihexadecylamine
16724-63-3

dihexadecylamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 73 percent / dimethylformamide / 6 h / 40 °C
2: 76 percent / AcOH, H2O / tetrahydrofuran / 4 h / 60 °C
View Scheme
n-hexadecanoyl chloride
112-67-4

n-hexadecanoyl chloride

dihexadecylamine
16724-63-3

dihexadecylamine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: ammonia / dichloromethane
2: lithium aluminium tetrahydride / tetrahydrofuran / 1 h
3: triethylamine / dichloromethane / 20 °C
4: lithium aluminium tetrahydride / tetrahydrofuran / 20 °C
View Scheme
Multi-step reaction with 2 steps
1: triethylamine / tetrahydrofuran; N,N-dimethyl-formamide / 21 h / 0 - 20 °C
2: lithium aluminium tetrahydride / tetrahydrofuran / 12 h / 55 °C
View Scheme
N-(hexadecanoyl)hexadecylamide
7332-71-0

N-(hexadecanoyl)hexadecylamide

dihexadecylamine
16724-63-3

dihexadecylamine

Conditions
ConditionsYield
With lithium aluminium tetrahydride In tetrahydrofuran at 20℃;
With lithium aluminium tetrahydride In tetrahydrofuran at 55℃; for 12h;
1-hexadecylcarboxylic acid
57-10-3

1-hexadecylcarboxylic acid

dihexadecylamine
16724-63-3

dihexadecylamine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: oxalyl dichloride / benzene / 3 h
2: triethylamine / dichloromethane / 20 °C
3: lithium aluminium tetrahydride / tetrahydrofuran / 20 °C
View Scheme
Multi-step reaction with 5 steps
1: oxalyl dichloride / benzene / 3 h
2: ammonia / dichloromethane
3: lithium aluminium tetrahydride / tetrahydrofuran / 1 h
4: triethylamine / dichloromethane / 20 °C
5: lithium aluminium tetrahydride / tetrahydrofuran / 20 °C
View Scheme
glyceroltripalmitate
555-44-2

glyceroltripalmitate

A

hexadecylamine
143-27-1

hexadecylamine

B

dihexadecylamine
16724-63-3

dihexadecylamine

Conditions
ConditionsYield
With ammonium hydroxide; hydrogen at 220℃; under 41254.1 Torr; for 36h; Autoclave;A 54 %Chromat.
B 19 %Chromat.
dihexadecylamine
16724-63-3

dihexadecylamine

Boc-His(Tos)-OH
35899-43-5

Boc-His(Tos)-OH

N,N-dihexadecyl-N2-tert-butoxycarbonyl-Nτ-tosyl-L-histidinamide

N,N-dihexadecyl-N2-tert-butoxycarbonyl-Nτ-tosyl-L-histidinamide

Conditions
ConditionsYield
With diethyl cyanophosphonate; triethylamine In dichloromethane at 0 - 25℃; for 1.5h;99%
4-(Dichloromethyl)phenoxy acetyl chloride
79910-33-1

4-(Dichloromethyl)phenoxy acetyl chloride

dihexadecylamine
16724-63-3

dihexadecylamine

N,N-dihexadecyl-4-(dichloromethyl)phenoxy acetamide
79910-34-2

N,N-dihexadecyl-4-(dichloromethyl)phenoxy acetamide

Conditions
ConditionsYield
With triethylamine In dichloromethane92%
succinic acid anhydride
108-30-5

succinic acid anhydride

dihexadecylamine
16724-63-3

dihexadecylamine

4-(dihexadecylamino)-4-oxobutanoic acid

4-(dihexadecylamino)-4-oxobutanoic acid

Conditions
ConditionsYield
In tetrahydrofuran at 20℃; for 24h;90.6%
In tetrahydrofuran at 20℃; for 18h;86.1%
In tetrahydrofuran at 20℃; for 24h;78.8%
Iodoacetic acid
64-69-7

Iodoacetic acid

dihexadecylamine
16724-63-3

dihexadecylamine

NN-dihexadecyl-2-iodoacetoamide
95930-25-9

NN-dihexadecyl-2-iodoacetoamide

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In dichloromethane 1.) 0 deg C, 2 h, 2.) r.t., 15 h;90%
dihexadecylamine
16724-63-3

dihexadecylamine

epichlorohydrin
106-89-8

epichlorohydrin

N,N-dihexadecyl(oxyranylmethyl)amine
32817-43-9

N,N-dihexadecyl(oxyranylmethyl)amine

Conditions
ConditionsYield
at 30 - 70℃; for 16h;84%
1,4-dioxane-2,6-dione
4480-83-5

1,4-dioxane-2,6-dione

dihexadecylamine
16724-63-3

dihexadecylamine

di-n-hexadecylcarbamoylmethoxyacetic acid
848872-95-7

di-n-hexadecylcarbamoylmethoxyacetic acid

Conditions
ConditionsYield
In tetrahydrofuran for 48h; Heating;80%
dihexadecylamine
16724-63-3

dihexadecylamine

trihexadecylamine
28947-77-5

trihexadecylamine

Conditions
ConditionsYield
With Co2Rh2/C In toluene at 180℃; under 760.051 Torr; for 18h; Autoclave; Inert atmosphere;74%
succinic acid anhydride
108-30-5

succinic acid anhydride

3-aminopropyltriethoxysilane
919-30-2

3-aminopropyltriethoxysilane

dihexadecylamine
16724-63-3

dihexadecylamine

[3-(((N,N-dihexadecylamino)succinyl)amino)propyl]triethoxysilane

[3-(((N,N-dihexadecylamino)succinyl)amino)propyl]triethoxysilane

Conditions
ConditionsYield
Stage #1: succinic acid anhydride; dihexadecylamine In toluene at 20℃; for 48h;
Stage #2: With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In ethanol; toluene for 3.5h;
Stage #3: 3-aminopropyltriethoxysilane In ethanol; toluene at 20℃; for 48h; Solvent; Reagent/catalyst; Molecular sieve;
68.5%
Condensation;
dihexadecylamine
16724-63-3

dihexadecylamine

3-bromo-isocyanatopropane
56017-72-2

3-bromo-isocyanatopropane

3-(3-bromopropyl)-1,1-dihexadecylurea
1215200-74-0

3-(3-bromopropyl)-1,1-dihexadecylurea

Conditions
ConditionsYield
In dichloromethane at 20℃; for 3h;67%
dihexadecylamine
16724-63-3

dihexadecylamine

Boc-Glu(OBzl)-OH
13574-13-5

Boc-Glu(OBzl)-OH

N,N-dihexadecyl-Nα-tert-butoxycarbonyl-O-benzyl-L-glutamic acid α-amide
748818-26-0

N,N-dihexadecyl-Nα-tert-butoxycarbonyl-O-benzyl-L-glutamic acid α-amide

Conditions
ConditionsYield
Stage #1: Boc-Glu(OBzl)-OH With dicyclohexyl-carbodiimide In dichloromethane at 0℃; for 0.5h;
Stage #2: dihexadecylamine In dichloromethane at 20℃;
66%
dihexadecylamine
16724-63-3

dihexadecylamine

3-(bromomethyl)benzonitrile
28188-41-2

3-(bromomethyl)benzonitrile

α-[N,N-di(n-hexadecyl)amino]-m-toluonitrile
59050-99-6

α-[N,N-di(n-hexadecyl)amino]-m-toluonitrile

Conditions
ConditionsYield
With potassium carbonate In hexane; ISOPROPYLAMIDE62%
With potassium carbonate In N,N-dimethyl acetamide; acetone
BOC-glycine
4530-20-5

BOC-glycine

dihexadecylamine
16724-63-3

dihexadecylamine

N,N-dihexadecyl-Nα-(tert-butoxycarbonyl)glycinamide
947261-02-1

N,N-dihexadecyl-Nα-(tert-butoxycarbonyl)glycinamide

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In dichloromethane at 0 - 20℃; for 16h;61.8%
succinic acid anhydride
108-30-5

succinic acid anhydride

dihexadecylamine
16724-63-3

dihexadecylamine

2-aminoethyl O-2',3',4',6'-tetraacetyl-β-D-glucopyranoside
350793-50-9

2-aminoethyl O-2',3',4',6'-tetraacetyl-β-D-glucopyranoside

Fmoc-Asp(Pip)-OH

Fmoc-Asp(Pip)-OH

N,N-dihexadecyl-N'-{1-hydrazinocarbonyl-2-[2-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-ethylcarbamoyl]-ethyl}-succinamide

N,N-dihexadecyl-N'-{1-hydrazinocarbonyl-2-[2-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-ethylcarbamoyl]-ethyl}-succinamide

Conditions
ConditionsYield
Multistep reaction.;60%
dihexadecylamine
16724-63-3

dihexadecylamine

Boc-(S)-Lys(2-Cl-Z)-OH
54613-99-9

Boc-(S)-Lys(2-Cl-Z)-OH

N,N-dihexadecyl-Nα-tert-butoxycarbonyl-Nε-2-chlorobenzyloxycarbonyl-L-lysine amide
864846-63-9

N,N-dihexadecyl-Nα-tert-butoxycarbonyl-Nε-2-chlorobenzyloxycarbonyl-L-lysine amide

Conditions
ConditionsYield
Stage #1: Boc-(S)-Lys(2-Cl-Z)-OH With dicyclohexyl-carbodiimide In dichloromethane at 0℃; for 0.5h;
Stage #2: dihexadecylamine In dichloromethane at 20℃;
59%
dihexadecylamine
16724-63-3

dihexadecylamine

11-(t-butoxycarbonylamino)-3,6,9-trioxaundecanoic acid-dicyclohexylammonium salt
1194727-21-3

11-(t-butoxycarbonylamino)-3,6,9-trioxaundecanoic acid-dicyclohexylammonium salt

C45H90N2O6

C45H90N2O6

Conditions
ConditionsYield
Stage #1: 11-(t-butoxycarbonylamino)-3,6,9-trioxaundecanoic acid-dicyclohexylammonium salt With 1,1'-carbonyldiimidazole In tetrahydrofuran at 0 - 25℃; for 1h;
Stage #2: dihexadecylamine at 20 - 40℃; for 8h;
59%
dihexadecylamine
16724-63-3

dihexadecylamine

3-tert-butyldimethylsilyloxy-17α-[3-aldehydopropane]-17β-estradiol
1048014-45-4

3-tert-butyldimethylsilyloxy-17α-[3-aldehydopropane]-17β-estradiol

3-tert-butyldimethylsilyloxy-17α-[3-N,N-dihexadecyl(amino)propane]-17β-estradiol
1048014-48-7

3-tert-butyldimethylsilyloxy-17α-[3-N,N-dihexadecyl(amino)propane]-17β-estradiol

Conditions
ConditionsYield
Stage #1: dihexadecylamine; 3-tert-butyldimethylsilyloxy-17α-[3-aldehydopropane]-17β-estradiol In dichloromethane at 20℃; for 0.5h;
Stage #2: With sodium cyanoborohydride In dichloromethane for 24h;
57.3%
dihexadecylamine
16724-63-3

dihexadecylamine

dicyclohexylammonium 1-(tert-butyloxycarbonylamino)-3,6-dioxa-octanoate
560088-79-1

dicyclohexylammonium 1-(tert-butyloxycarbonylamino)-3,6-dioxa-octanoate

C43H86N2O5

C43H86N2O5

Conditions
ConditionsYield
Stage #1: dicyclohexylammonium 1-(tert-butyloxycarbonylamino)-3,6-dioxa-octanoate With 1,1'-carbonyldiimidazole In tetrahydrofuran at 0 - 25℃; for 1h;
Stage #2: dihexadecylamine In tetrahydrofuran at 20 - 50℃; for 19h;
55%
dihexadecylamine
16724-63-3

dihexadecylamine

Boc-His(Bzl)-OH
20898-44-6

Boc-His(Bzl)-OH

N,N-dihexadecyl-Nα-(t-butoxycarbonyl)-Nim-benzyl-L-histidinamide
98189-02-7

N,N-dihexadecyl-Nα-(t-butoxycarbonyl)-Nim-benzyl-L-histidinamide

Conditions
ConditionsYield
With benzotriazol-1-ol; dicyclohexyl-carbodiimide In dichloromethane 1) 3 h; 0 deg C; 2) 15 h; room temp.;54%
dihexadecylamine
16724-63-3

dihexadecylamine

2-(tert-butyldimethylsilyloxy)ethyl bromide
86864-60-0

2-(tert-butyldimethylsilyloxy)ethyl bromide

O-tert-butyldimethylsilyl N-2-hydroxyethyl-N,N-di-n-hexadecylamine
802903-68-0

O-tert-butyldimethylsilyl N-2-hydroxyethyl-N,N-di-n-hexadecylamine

Conditions
ConditionsYield
With potassium carbonate In ethyl acetate for 40h; Heating;46%
dihexadecylamine
16724-63-3

dihexadecylamine

N(α)-t-butoxycarbonyl-N(ϖ)-benzyloxymethyl-L-histidine
83468-83-1

N(α)-t-butoxycarbonyl-N(ϖ)-benzyloxymethyl-L-histidine

N,N-dihexadecyl-Nα-tert-butoxycarbonyl-Nim-benzyloxymethyl-L-histidine amide
798551-32-3

N,N-dihexadecyl-Nα-tert-butoxycarbonyl-Nim-benzyloxymethyl-L-histidine amide

Conditions
ConditionsYield
With diethyl cyanophosphonate; triethylamine In dichloromethane at 20℃; for 2h;46%
With benzotriazol-1-ol; dicyclohexyl-carbodiimide In dichloromethane at 0 - 20℃; for 45h;31%
dihexadecylamine
16724-63-3

dihexadecylamine

2,2:4,5-di-O-isopropylidene-D-arabinose
13039-93-5

2,2:4,5-di-O-isopropylidene-D-arabinose

Dihexadecyl-((4S,5R,4'R)-2,2,2',2'-tetramethyl-[4,4']bi[[1,3]dioxolanyl]-5-ylmethyl)-amine
382156-59-4

Dihexadecyl-((4S,5R,4'R)-2,2,2',2'-tetramethyl-[4,4']bi[[1,3]dioxolanyl]-5-ylmethyl)-amine

Conditions
ConditionsYield
Stage #1: dihexadecylamine; 2,2:4,5-di-O-isopropylidene-D-arabinose In dichloromethane for 0.5h;
Stage #2: With sodium cyanoborohydride In dichloromethane at 20℃; for 30h; Further stages.;
40%
dihexadecylamine
16724-63-3

dihexadecylamine

1-aldehydo-2,3:5,6-diisopropylidene-4-(tert-butyl-dimethylsilyloxy)-D-galactose
745818-26-2

1-aldehydo-2,3:5,6-diisopropylidene-4-(tert-butyl-dimethylsilyloxy)-D-galactose

1-deoxy-1-[di-n-hexadecyl(amino)]-2,3:5,6-diisopropylidene-4-(tert-butyl-dimethylsilyloxy)-D-galactose
745818-27-3

1-deoxy-1-[di-n-hexadecyl(amino)]-2,3:5,6-diisopropylidene-4-(tert-butyl-dimethylsilyloxy)-D-galactose

Conditions
ConditionsYield
Stage #1: dihexadecylamine; 1-aldehydo-2,3:5,6-diisopropylidene-4-(tert-butyl-dimethylsilyloxy)-D-galactose In dichloromethane at 20℃; for 0.5h;
Stage #2: With sodium cyanoborohydride In dichloromethane for 24h;
24%
azelaic acid
123-99-9

azelaic acid

dihexadecylamine
16724-63-3

dihexadecylamine

8-dihexadecylcarbamoyl-octanoic acid

8-dihexadecylcarbamoyl-octanoic acid

formaldehyd
50-00-0

formaldehyd

formic acid
64-18-6

formic acid

dihexadecylamine
16724-63-3

dihexadecylamine

N-hexadecyl-N-methylhexadecan-1-amine
16724-61-1

N-hexadecyl-N-methylhexadecan-1-amine

Conditions
ConditionsYield
With ethanol anfangs auf 40-60grad,zuletzt auf Siedetemperatur;
Adipic acid
124-04-9

Adipic acid

dihexadecylamine
16724-63-3

dihexadecylamine

N,N-dihexadecyl-adipamic acid

N,N-dihexadecyl-adipamic acid

16724-63-3Relevant articles and documents

Preparation and characterization of a novel organic-inorganic nanohybrid "cerasome" formed with a liposomal membrane and silicate surface

Katagiri, Kiyofumi,Hashizume, Mineo,Ariga, Katsuhiko,Terashima, Takashi,Kikuchi, Jun-Ichi

, p. 5272 - 5281 (2007)

A novel class of organic-inorganic hybrids, the so-called cerasomes, which have a bilayer vesicular structure and a silicate surface, has been synthesized by combination of sol-gel reaction and self-assembly of organoalkoxysilanes with a molecular structure analogous to lipids. We have synthesized two cerasome-forming organoalkoxysilanes, N-[N-(3-triethoxysilyl)propylsuccinamoyl] dihexadecylamine (1) and N,N-dihexadecyl-;N"-[6-[(3-triethoxysilyl) propyldimethylammonio]hexanoyl]glycinamide bromide (2), and investigated the synthetic conditions of the cerasomes and their structural characteristics. For the proamphi philic 1, the cerasome was obtained under restricted pH conditions where acid-catalyzed hydrolysis of the triethoxysilyl moiety proceeded without disturbing the vesicle formation. In contrast, the amphiphilic 2, additionally having a hydrophilic quaternary ammonium group, formed stable dispersions of the cerasome in a wide pH range. The hydrolysis behavior of the triethoxysilyl groups was monitored by 1H NMR spectroscopy. Morphology of the cerasomes having the liposomal vesicular structure was confirmed by TEM observations. Extent of the development of siloxane networks through condensation among the silanol groups on the cerasome surface was evaluated by using MALDI-TOF-MS spectrometry. Formation of oligomers of the cerasome-forming lipids in the vesicle was clearly confirmed. Due to the siloxane network formation, the cerasome showed remarkably high morphological stability compared with a reference liposome, as evaluated by surfactant dissolution measurements.

Gadolinium DO3A derivatives mimicking phospholipids; preparation and in vitro evaluation as pH responsive MRI contrast agents

Hovland,Gl?ga?rd,Aasen,Klaveness

, p. 929 - 933 (2001)

A series of Gd-DO3A derivatives (8a-d) mimicking phospholipids have been prepared. Two of the complexes, Gd-HADB-DO3A (8a) and Gd-HADO-DO3A (8b), have been evaluated as pH responsive MRI contrast agents in vitro. The T1-relaxivity (r1/sub

Selective Transformations of Triglycerides into Fatty Amines, Amides, and Nitriles by using Heterogeneous Catalysis

Jamil, Md. A. R.,Siddiki, S. M. A. Hakim,Touchy, Abeda Sultana,Rashed, Md. Nurnobi,Poly, Sharmin Sultana,Jing, Yuan,Ting, Kah Wei,Toyao, Takashi,Maeno, Zen,Shimizu, Ken-ichi

, p. 3115 - 3125 (2019/04/26)

The use of triglycerides as an important class of biomass is an effective strategy to realize a more sustainable society. Herein, three heterogeneous catalytic methods are reported for the selective one-pot transformation of triglycerides into value-added chemicals: i) the reductive amination of triglycerides into fatty amines with aqueous NH3 under H2 promoted by ZrO2-supported Pt clusters; ii) the amidation of triglycerides under gaseous NH3 catalyzed by high-silica H-beta (Hβ) zeolite at 180 °C; iii) the Hβ-promoted synthesis of nitriles from triglycerides and gaseous NH3 at 220 °C. These methods are widely applicable to the transformation of various triglycerides (C4–C18 skeletons) into the corresponding amines, amides, and nitriles.

A medicine silicon lipid ultrasound contrast agents in the preparation method and application of

-

Paragraph 0046; 0049, (2018/07/30)

The invention provides a preparation method of a drug-loaded silicone grease ultrasonic contrast agent. The preparation method comprises fully dissolving silicone grease, polyethylene glycol phosphate derivatives and a fat-soluble anticancer drug in an organic solvent, adding water into the solution, carrying out whirling, removing the organic solvent, supplying water with a volume 3 times that of the solution into the solution, carrying out ultrasonic disintegration by an ultrasonic disintegrator, simultaneously and fast adding liquid fluorocarbon into the solution to obtain a pre-emulsion, and carrying out dialysis on the pre-emulsion in PBS for 1h to obtain a product. The preparation method has simple processes. The product has the average particle size of about 100nm and is conducive to aggregation at a tumor position by internal EPR effects. Siloxane silicone grease network distribution substantially improves structure stability and prolongs internal blood circulation time. Through HIFU, the drug-loaded silicone grease ultrasonic contrast agent release drugs at a local part of tumor tissue, drug treatment targeting is improved, HIFU treatment effects are substantially improved and HIFU-chemotherapy combined treatment is realized.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 16724-63-3